{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T04:09:29Z","timestamp":1777003769347,"version":"3.51.4"},"reference-count":88,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.phrs.2020.105096","type":"journal-article","created":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T21:19:49Z","timestamp":1595539189000},"page":"105096","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Novel anti-thrombotic mechanisms mediated by Mas receptor as result of balanced activities between the kallikrein\/kinin and the renin-angiotensin systems"],"prefix":"10.1016","volume":"160","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2524-3730","authenticated-orcid":false,"given":"Chao","family":"Fang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3884-6234","authenticated-orcid":false,"given":"Alvin H.","family":"Schmaier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.phrs.2020.105096_bib0005","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1056\/NEJMra0801082","article-title":"Mechanisms of thrombus formation","volume":"359","author":"Furie","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.phrs.2020.105096_bib0010","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/nm.2515","article-title":"Arterial thrombosis--insidious, unpredictable and deadly","volume":"17","author":"Jackson","year":"2011","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.phrs.2020.105096_bib0015","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/MOH.0000000000000271","article-title":"Antithrombotic potential of the contact activation pathway","volume":"23","author":"Schmaier","year":"2016","journal-title":"Curr. Opin. Hematol."},{"issue":"3","key":"10.1016\/j.phrs.2020.105096_bib0020","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1084\/jem.20052458","article-title":"Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis","volume":"203","author":"Kleinschnitz","year":"2006","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.phrs.2020.105096_bib0025","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1182\/blood-2014-01-550285","article-title":"Reduced thrombosis in Klkb1-\/- mice is mediated by increased Mas receptor, prostacyclin, Sirt1, and KLF4 and decreased tissue factor","volume":"125","author":"Stavrou","year":"2015","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.phrs.2020.105096_bib0030","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1160\/TH11-10-0682","article-title":"Effects of plasma kallikrein deficiency on haemostasis and thrombosis in mice: murine ortholog of the Fletcher trait","volume":"107","author":"Bird","year":"2012","journal-title":"Thromb. Haemost."},{"issue":"3","key":"10.1016\/j.phrs.2020.105096_bib0035","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1182\/blood-2007-06-092338","article-title":"Deletion of murine kininogen gene 1 (mKng1) causes loss of plasma kininogen and delays thrombosis","volume":"111","author":"Merkulov","year":"2008","journal-title":"Blood"},{"issue":"19","key":"10.1016\/j.phrs.2020.105096_bib0040","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.1182\/blood-2012-06-440057","article-title":"Kininogen deficiency protects from ischemic neurodegeneration in mice by reducing thrombosis, blood-brain barrier damage, and inflammation","volume":"120","author":"Langhauser","year":"2012","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.phrs.2020.105096_bib0045","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/MOH.0000000000000367","article-title":"Novel targets for anticoagulants lacking bleeding risk","volume":"24","author":"Bickmann","year":"2017","journal-title":"Curr. Opin. Hematol."},{"issue":"15","key":"10.1016\/j.phrs.2020.105096_bib0050","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1182\/blood-2012-09-459156","article-title":"Angiotensin 1-7 and Mas decrease thrombosis in Bdkrb2-\/- mice by increasing NO and prostacyclin to reduce platelet spreading and glycoprotein VI activation","volume":"121","author":"Fang","year":"2013","journal-title":"Blood"},{"issue":"24","key":"10.1016\/j.phrs.2020.105096_bib0055","doi-asserted-by":"crossref","first-page":"5111","DOI":"10.1182\/blood-2009-08-236430","article-title":"Factor XII stimulates ERK1\/2 and Akt through uPAR, integrins, and the EGFR to initiate angiogenesis","volume":"115","author":"LaRusch","year":"2010","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.phrs.2020.105096_bib0060","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1055\/s-0038-1675614","article-title":"Role of endothelial cells in acute and chronic thrombosis","volume":"39","author":"Bochenek","year":"2019","journal-title":"Hamostaseologie"},{"issue":"2","key":"10.1016\/j.phrs.2020.105096_bib0065","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1160\/TH09-11-0764","article-title":"Functional regulation of vascular and platelet activity during thrombosis by nitric oxide and endothelial nitric oxide synthase","volume":"104","author":"Moore","year":"2010","journal-title":"Thromb. Haemost."},{"issue":"9","key":"10.1016\/j.phrs.2020.105096_bib0070","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1161\/CIRCRESAHA.119.314927","article-title":"Cell-specific gene deletion reveals the antithrombotic function of COX1 and explains the vascular COX1\/prostacyclin paradox","volume":"125","author":"Mitchell","year":"2019","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.phrs.2020.105096_bib0075","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1055\/s-0038-1655981","article-title":"Anticoagulant properties of the vascular endothelium","volume":"77","author":"Bombeli","year":"1997","journal-title":"Thromb. Haemost."},{"issue":"6","key":"10.1016\/j.phrs.2020.105096_bib0080","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1161\/ATVBAHA.118.311102","article-title":"Glycosaminoglycan neutralization in coagulation control","volume":"38","author":"Sobczak","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"2","key":"10.1016\/j.phrs.2020.105096_bib0085","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1182\/blood-2017-12-768994","article-title":"Exploring traditional and nontraditional roles for thrombomodulin","volume":"132","author":"Loghmani","year":"2018","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.phrs.2020.105096_bib0090","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1161\/01.ATV.0000189309.05924.88","article-title":"Stimulated tissue plasminogen activator release as a marker of endothelial function in humans","volume":"25","author":"Oliver","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.phrs.2020.105096_bib0095","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/jth.13194","article-title":"The contact activation and kallikrein\/kinin systems: pathophysiologic and physiologic activities","volume":"14","author":"Schmaier","year":"2016","journal-title":"J. Thromb. Haemost."},{"issue":"4","key":"10.1016\/j.phrs.2020.105096_bib0100","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/rth2.12235","article-title":"Factor XII - what\u2019s important but not commonly thought about","volume":"3","author":"Schmaier","year":"2019","journal-title":"Res. Pract. Thromb. Haemost."},{"issue":"10","key":"10.1016\/j.phrs.2020.105096_bib0105","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1182\/blood.2019001643","article-title":"Red blood cell microvesicles activate the contact system, leading to factor IX activation via 2 independent pathways","volume":"135","author":"Noubouossie","year":"2020","journal-title":"Blood"},{"issue":"21","key":"10.1016\/j.phrs.2020.105096_bib0110","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V120.21.3362.3362","article-title":"FXII promotes coagulation in a FXI and FIX independent manner","volume":"120","author":"Puy","year":"2012","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.phrs.2020.105096_bib0115","doi-asserted-by":"crossref","first-page":"4554","DOI":"10.1182\/blood-2003-07-2510","article-title":"Recombinant prolylcarboxypeptidase activates plasma prekallikrein","volume":"103","author":"Shariat-Madar","year":"2004","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.phrs.2020.105096_bib0120","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.intimp.2007.08.022","article-title":"Assembly, activation, and physiologic influence of the plasma kallikrein\/kinin system","volume":"8","author":"Schmaier","year":"2008","journal-title":"Int. Immunopharmacol."},{"issue":"20","key":"10.1016\/j.phrs.2020.105096_bib0125","doi-asserted-by":"crossref","first-page":"17962","DOI":"10.1074\/jbc.M106101200","article-title":"Identification and characterization of prolylcarboxypeptidase as an endothelial cell prekallikrein activator","volume":"277","author":"Shariat-Madar","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.phrs.2020.105096_bib0130","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/14728222.2018.1409724","article-title":"Kinin B1 receptors as a therapeutic target for inflammation","volume":"22","author":"Qadri","year":"2018","journal-title":"Expert Opin. Ther. Targets"},{"issue":"10","key":"10.1016\/j.phrs.2020.105096_bib0135","doi-asserted-by":"crossref","first-page":"3819","DOI":"10.1182\/blood.V90.10.3819","article-title":"Contact system: a vascular biology modulator with anticoagulant, profibrinolytic, antiadhesive, and proinflammatory attributes","volume":"90","author":"Colman","year":"1997","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.phrs.2020.105096_bib0140","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1182\/blood.V66.4.835.835","article-title":"Tissue plasminogen activator release in vivo in response to vasoactive agents","volume":"66","author":"Smith","year":"1985","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.phrs.2020.105096_bib0145","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/0049-3848(80)90201-7","article-title":"Effect of bradykinin and thrombin on prostacyclin synthesis in endothelial cells from calf and pig aorta and human umbilical cord vein","volume":"18","author":"Hong","year":"1980","journal-title":"Thromb. Res."},{"issue":"40","key":"10.1016\/j.phrs.2020.105096_bib0150","doi-asserted-by":"crossref","first-page":"6215","DOI":"10.2174\/1381612823666170622112253","article-title":"Role of bradykinin in the regulation of endothelial nitric oxide synthase expression by cardiovascular drugs","volume":"23","author":"Su","year":"2017","journal-title":"Curr. Pharm. Des."},{"issue":"1","key":"10.1016\/j.phrs.2020.105096_bib0155","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1152\/ajpregu.00535.2002","article-title":"The kallikrein-kinin and the renin-angiotensin systems have a multilayered interaction","volume":"285","author":"Schmaier","year":"2003","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"8","key":"10.1016\/j.phrs.2020.105096_bib0160","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1172\/JCI0215490","article-title":"The plasma kallikrein-kinin system counterbalances the renin-angiotensin system","volume":"109","author":"Schmaier","year":"2002","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.phrs.2020.105096_bib0165","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1161\/01.CIR.94.3.517","article-title":"Bradykinin and its metabolite, Arg-Pro-Pro-Gly-Phe, are selective inhibitors of \u03b1-thrombin-induced platelet activation","volume":"94","author":"Hasan","year":"1996","journal-title":"Circulation"},{"issue":"17","key":"10.1016\/j.phrs.2020.105096_bib0170","doi-asserted-by":"crossref","first-page":"14838","DOI":"10.1074\/jbc.M200581200","article-title":"Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase","volume":"277","author":"Vickers","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2020.105096_bib0175","first-page":"419","article-title":"Prothrombotic effects of angiotensin","volume":"45","author":"Brown","year":"2000","journal-title":"Adv. Intern. Med."},{"issue":"6","key":"10.1016\/j.phrs.2020.105096_bib0180","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1055\/s-0038-1656136","article-title":"Angiotensin II increases plasminogen activator inhibitor-1 and tissue factor mRNA expression without changing that of tissue type plasminogen activator or tissue factor pathway inhibitor in cultured rat aortic endothelial cells","volume":"77","author":"Nishimura","year":"1997","journal-title":"Thromb. Haemost."},{"issue":"3","key":"10.1016\/j.phrs.2020.105096_bib0185","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1172\/JCI117786","article-title":"Angiotensin II induces plasminogen activator inhibitor-1 and -2 expression in vascular endothelial and smooth muscle cells","volume":"95","author":"Feener","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.phrs.2020.105096_bib0190","doi-asserted-by":"crossref","DOI":"10.2174\/1381612826666200115092015","article-title":"Emerging role of angiotensin AT2 receptor in anti-inflammation: an update","author":"Patel","year":"2020","journal-title":"Curr. Pharm. Des."},{"issue":"6","key":"10.1016\/j.phrs.2020.105096_bib0195","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1160\/TH12-06-0396","article-title":"The angiotensin-converting enzyme 2\/angiotensin-(1-7)\/Mas receptor axis: a potential target for treating thrombotic diseases","volume":"108","author":"Fraga-Silva","year":"2012","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.phrs.2020.105096_bib0200","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.phrs.2017.06.013","article-title":"Current topics in angiotensin II type 1 receptor research: focus on inverse agonism, receptor dimerization and biased agonism","volume":"123","author":"Takezako","year":"2017","journal-title":"Pharmacol. Res."},{"issue":"3","key":"10.1016\/j.phrs.2020.105096_bib0205","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.bcp.2014.01.019","article-title":"Vasopressor meets vasodepressor: the AT1-B2 receptor heterodimer","volume":"88","author":"Quitterer","year":"2014","journal-title":"Biochem. Pharmacol."},{"issue":"1\u20132","key":"10.1016\/j.phrs.2020.105096_bib0210","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.cell.2018.10.050","article-title":"Beta-Arrestin1 prevents preeclampsia by downregulation of mechanosensitive AT1-B2 receptor heteromers","volume":"176","author":"Quitterer","year":"2019","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.phrs.2020.105096_bib0215","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1161\/01.HYP.0000228997.88162.a8","article-title":"Angiotensin II type 2 receptor-bradykinin B2 receptor functional heterodimerization","volume":"48","author":"Abadir","year":"2006","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.phrs.2020.105096_bib0220","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1161\/HYPERTENSIONAHA.116.07874","article-title":"Heteromerization between the bradykinin B2 receptor and the angiotensin-(1-7) mas receptor: functional consequences","volume":"68","author":"Cerrato","year":"2016","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.phrs.2020.105096_bib0225","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11906-018-0845-3","article-title":"Dimerization of AT2 and mas receptors in control of blood pressure","volume":"20","author":"Patel","year":"2018","journal-title":"Curr. Hypertens. Rep."},{"issue":"5\u20136","key":"10.1016\/j.phrs.2020.105096_bib0230","doi-asserted-by":"crossref","first-page":"210","DOI":"10.2119\/molmed.2009.00160","article-title":"ACE2 activation promotes antithrombotic activity","volume":"16","author":"Fraga-Silva","year":"2010","journal-title":"Mol. Med."},{"issue":"4","key":"10.1016\/j.phrs.2020.105096_bib0235","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1124\/pr.113.008136","article-title":"MAS and its related G protein-coupled receptors","volume":"66","author":"Bader","year":"2014","journal-title":"Mrgprs. Pharmacol Rev."},{"issue":"Suppl. 2","key":"10.1016\/j.phrs.2020.105096_bib0240","first-page":"II56","article-title":"Production of angiotensin-(1-7) by human vascular endothelium","volume":"19","author":"Santos","year":"1992","journal-title":"Hypertension."},{"key":"10.1016\/j.phrs.2020.105096_bib0245","doi-asserted-by":"crossref","first-page":"34621","DOI":"10.1038\/srep34621","article-title":"Angiotensin-(1-7) abrogates angiotensin II-induced proliferation, migration and inflammation in VSMCs through inactivation of ROS-mediated PI3K\/Akt and MAPK\/ERK signaling pathways","volume":"6","author":"Zhang","year":"2016","journal-title":"Sci. Rep."},{"issue":"1\u20132","key":"10.1016\/j.phrs.2020.105096_bib0250","doi-asserted-by":"crossref","first-page":"28","DOI":"10.2119\/2007-00073.Fraga-Silva","article-title":"The antithrombotic effect of angiotensin-(1-7) involves mas-mediated NO release from platelets","volume":"14","author":"Fraga-Silva","year":"2008","journal-title":"Mol Med."},{"issue":"5","key":"10.1016\/j.phrs.2020.105096_bib0255","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1161\/01.HYP.0000035396.27909.40","article-title":"Antithrombotic effect of captopril and losartan is mediated by angiotensin-(1-7)","volume":"40","author":"Kucharewicz","year":"2002","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.phrs.2020.105096_bib0260","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/01.fjc.0000176729.51819.a6","article-title":"Angiotensin-(1-7) enhances anti-aggregatory effects of the nitric oxide donor sodium nitroprusside","volume":"46","author":"Rajendran","year":"2005","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"1","key":"10.1016\/j.phrs.2020.105096_bib0265","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1161\/01.HYP.0000251865.35728.2f","article-title":"Angiotensin-(1-7) through receptor Mas mediates endothelial nitric oxide synthase activation via Akt-dependent pathways","volume":"49","author":"Sampaio","year":"2007","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.phrs.2020.105096_bib0270","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0022-3565(24)37208-8","article-title":"Signal transduction mechanisms involved in angiotensin-(1-7)-stimulated arachidonic acid release and prostanoid synthesis in rabbit aortic smooth muscle cells","volume":"284","author":"Muthalif","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"8","key":"10.1016\/j.phrs.2020.105096_bib0275","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1111\/bph.14167","article-title":"Eicosanoids, prostacyclin and cyclooxygenase in the cardiovascular system","volume":"176","author":"Mitchell","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2020.105096_bib0280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cellsig.2017.05.012","article-title":"The many faces of compartmentalized PKA signalosomes","volume":"37","author":"Torres-Quesada","year":"2017","journal-title":"Cell. Signal."},{"issue":"8","key":"10.1016\/j.phrs.2020.105096_bib0285","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.bmcl.2017.02.065","article-title":"Exchange proteins directly activated by cAMP (EPACs): emerging therapeutic targets","volume":"27","author":"Wang","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.phrs.2020.105096_bib0290","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.lfs.2016.03.059","article-title":"Activation of PKA and Epac proteins by cyclic AMP depletes intracellular calcium stores and reduces calcium availability for vasoconstriction","volume":"155","author":"Cuinas","year":"2016","journal-title":"Life Sci."},{"issue":"5","key":"10.1016\/j.phrs.2020.105096_bib0295","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1161\/CIRCRESAHA.115.306529","article-title":"Cyclic AMP sensor EPAC proteins and their role in cardiovascular function and disease","volume":"118","author":"Lezoualc\u2019h","year":"2016","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.phrs.2020.105096_bib0300","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2174\/157340641202160208195923","article-title":"Role of calcium in platelet activation: novel insights and pharmacological implications","volume":"12","author":"Davlouros","year":"2016","journal-title":"Med Chem."},{"issue":"11","key":"10.1016\/j.phrs.2020.105096_bib0305","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1161\/ATVBAHA.109.193367","article-title":"PPAR\u03b2\/\u03b4 agonists modulate platelet function via a mechanism involving PPAR receptors and specific association\/repression of PKC\u03b1--brief report","volume":"29","author":"Ali","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"13","key":"10.1016\/j.phrs.2020.105096_bib0310","first-page":"3146","article-title":"Novel endogenous negative modulators of platelet function as potential anti-thrombotic targets","volume":"21","author":"Li","year":"2017","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"2","key":"10.1016\/j.phrs.2020.105096_bib0315","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1161\/HYPERTENSIONAHA.117.09906","article-title":"Cyclooxygenase-2 selectively controls renal blood flow through a novel PPAR\u03b2\/\u03b4-dependent vasodilator pathway","volume":"71","author":"Kirkby","year":"2018","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.phrs.2020.105096_bib0320","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1086\/674755","article-title":"The peroxisome proliferator-activated receptor \u03b2\/\u03b4 agonist GW0742 has direct protective effects on right heart hypertrophy","volume":"3","author":"Kojonazarov","year":"2013","journal-title":"Pulm. Circ."},{"issue":"1","key":"10.1016\/j.phrs.2020.105096_bib0325","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1161\/CIRCRESAHA.108.176057","article-title":"Angiogenic function of prostacyclin biosynthesis in human endothelial progenitor cells","volume":"103","author":"He","year":"2008","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2020.105096_bib0330","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.ejmech.2019.01.067","article-title":"Role of PPAR receptor in different diseases and their ligands: physiological importance and clinical implications","volume":"166","author":"Mirza","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"11","key":"10.1016\/j.phrs.2020.105096_bib0335","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1161\/CIRCULATIONAHA.112.097295","article-title":"Cyclooxygenase-2-derived prostacyclin regulates arterial thrombus formation by suppressing tissue factor in a sirtuin-1-dependent-manner","volume":"126","author":"Barbieri","year":"2012","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.phrs.2020.105096_bib0340","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1084\/jem.20070828","article-title":"COX-2 suppresses tissue factor expression via endocannabinoid-directed PPAR\u03b4 activation","volume":"204","author":"Ghosh","year":"2007","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.phrs.2020.105096_bib0345","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ijcard.2007.12.119","article-title":"Effects of a stable prostacyclin analogue beraprost sodium on VEGF and PAI-1 gene expression in vascular smooth muscle cells","volume":"132","author":"Atsuta","year":"2009","journal-title":"Int. J. Cardiol."},{"issue":"17","key":"10.1016\/j.phrs.2020.105096_bib0350","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1089\/ars.2013.5374","article-title":"Prostacyclin signaling boosts NADPH oxidase 4 in the endothelium promoting cytoprotection and angiogenesis","volume":"20","author":"Peshavariya","year":"2014","journal-title":"Antioxid. Redox Signal."},{"issue":"132","key":"10.1016\/j.phrs.2020.105096_bib0355","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003787","article-title":"Vascular COX-2 modulates blood pressure and thrombosis in mice","volume":"4","author":"Yu","year":"2012","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.phrs.2020.105096_bib0360","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1172\/JCI27291","article-title":"Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities","volume":"116","author":"Grosser","year":"2006","journal-title":"J. Clin. Invest."},{"issue":"7","key":"10.1016\/j.phrs.2020.105096_bib0365","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1161\/CIRCRESAHA.118.312498","article-title":"Sirtuins and NAD(+) in the Development and Treatment of Metabolic and Cardiovascular Diseases","volume":"123","author":"Kane","year":"2018","journal-title":"Circ. Res."},{"issue":"48","key":"10.1016\/j.phrs.2020.105096_bib0370","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1093\/eurheartj\/ehv290","article-title":"Protective effects of sirtuins in cardiovascular diseases: from bench to bedside","volume":"36","author":"Winnik","year":"2015","journal-title":"Eur. Heart J."},{"issue":"2","key":"10.1016\/j.phrs.2020.105096_bib0375","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1093\/cvr\/cvq339","article-title":"Sirt1 inhibition promotes in vivo arterial thrombosis and tissue factor expression in stimulated cells","volume":"89","author":"Breitenstein","year":"2011","journal-title":"Cardiovasc. Res."},{"issue":"10","key":"10.1016\/j.phrs.2020.105096_bib0380","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1182\/blood-2011-04-350413","article-title":"Sirt1 protects against thrombomodulin down-regulation and lung coagulation after particulate matter exposure","volume":"119","author":"Wu","year":"2012","journal-title":"Blood"},{"issue":"17","key":"10.1016\/j.phrs.2020.105096_bib0385","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20174132","article-title":"Effect of autophagy regulated by Sirt1\/FoxO1 pathway on the release of factors promoting thrombosis from vascular endothelial cells","volume":"20","author":"Wu","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.phrs.2020.105096_bib0390","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1055\/s-0038-1676987","article-title":"Deep vein thrombosis is modulated by inflammation regulated via sirtuin 1\/NF-kappaB signalling pathway in a rat model","volume":"119","author":"Yao","year":"2019","journal-title":"Thromb. Haemost."},{"issue":"8","key":"10.1016\/j.phrs.2020.105096_bib0395","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1093\/cvr\/cvy036","article-title":"Loss of Sirt3 accelerates arterial thrombosis by increasing formation of neutrophil extracellular traps and plasma tissue factor activity","volume":"114","author":"Gaul","year":"2018","journal-title":"Cardiovasc. Res."},{"issue":"1","key":"10.1016\/j.phrs.2020.105096_bib0400","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1182\/blood-2006-01-0094","article-title":"Bradykinin B2 receptor knockout mice are protected from thrombosis by increased nitric oxide and prostacyclin","volume":"108","author":"Shariat-Madar","year":"2006","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.phrs.2020.105096_bib0405","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1084\/jem.20050664","article-title":"Defective thrombus formation in mice lacking coagulation factor XII","volume":"202","author":"Renne","year":"2005","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.phrs.2020.105096_bib0410","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.cell.2009.11.001","article-title":"Platelet polyphosphates are proinflammatory and procoagulant mediators in vivo","volume":"139","author":"Muller","year":"2009","journal-title":"Cell"},{"issue":"76","key":"10.1016\/j.phrs.2020.105096_bib0415","article-title":"Polyphosphate as a Target for Interference With Inflammation and Thrombosis","volume":"6","author":"Mailer","year":"2019","journal-title":"Front. Med. (Lausanne)"},{"issue":"12","key":"10.1016\/j.phrs.2020.105096_bib0420","doi-asserted-by":"crossref","first-page":"4727","DOI":"10.1172\/JCI66056","article-title":"Endothelial Kruppel-like factor 4 protects against atherothrombosis in mice","volume":"122","author":"Zhou","year":"2012","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.phrs.2020.105096_bib0425","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5551\/jat.32326","article-title":"Microparticle and atherothrombotic diseases","volume":"23","author":"Nomura","year":"2016","journal-title":"J. Atheroscler. Thromb."},{"issue":"5","key":"10.1016\/j.phrs.2020.105096_bib0430","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.thromres.2005.01.013","article-title":"Detached endothelial cells and microparticles as sources of tissue factor activity","volume":"116","author":"Kushak","year":"2005","journal-title":"Thromb. Res."},{"issue":"Suppl. 1","key":"10.1016\/j.phrs.2020.105096_bib0435","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1016\/j.thromres.2010.01.036","article-title":"Formation of procoagulant microparticles and properties","volume":"125","author":"Freyssinet","year":"2010","journal-title":"Thromb. Res."},{"issue":"13","key":"10.1016\/j.phrs.2020.105096_bib0440","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1161\/CIRCULATIONAHA.109.924761","article-title":"Factor XIIa inhibitor recombinant human albumin Infestin-4 abolishes occlusive arterial thrombus formation without affecting bleeding","volume":"121","author":"Hagedorn","year":"2010","journal-title":"Circulation"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661820314043?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661820314043?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:17:15Z","timestamp":1760912235000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661820314043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":88,"alternative-id":["S1043661820314043"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2020.105096","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel anti-thrombotic mechanisms mediated by Mas receptor as result of balanced activities between the kallikrein\/kinin and the renin-angiotensin systems","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2020.105096","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105096"}}